Clarkston Skin Research | Clarkston, MI

Research site
5701 Bow Pointe Drive, Suite 217, Clarkston, Michigan, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 20
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hai...

Hair Diseases
Drug: Baricitinib
Drug: Placebo

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the...

Active, not recruiting
Alopecia Areata
Drug: Baricitinib
Drug: Placebo

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Alopecia Areata
Drug: CTP-543

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial conditions

Atopic Dermatitis (8 trials)
Dermatitis (8 trials)
Eczema (8 trials)
Alopecia (4 trials)
Alopecia Areata (4 trials)
Psoriasis (3 trials)
Skin Diseases (2 trials)
Acne Vulgaris (1 trial)
Actinic Keratosis (1 trial)
Anatomical Pathological... (1 trial)

And 18 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems